Cargando…
The effect of istradefylline for Parkinson’s disease: A meta-analysis
Adenosine A(2A) receptor antagonists are an alternative treatment strategy for Parkinson’s disease. Several randomized placebo controlled studies have tested the effect of A(2A) receptor antagonist istradefylline, and more robust evidence has been acquired. This meta-analysis aimed to provide eviden...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740127/ https://www.ncbi.nlm.nih.gov/pubmed/29269791 http://dx.doi.org/10.1038/s41598-017-18339-1 |